The 2025 State of Regulatory Affairs and Compliance Report
Download Report
Is your organization prepared for 2025’s regulatory complexities?
The regulatory landscape in 2025 is more complex than ever, with new advancements in AI, gene therapy, and growing concerns about data privacy and sustainability.
The 2025 State of Regulatory Affairs & Compliance Report from RegASK explores how businesses in sectors like life sciences and consumer products can stay ahead of these changes. Drawing on insights from 145+ industry experts, the report outlines key regulatory challenges, the role of AI in compliance, and the risks of falling behind.
Key insights you’ll discover :
- The impact of escalating regulatory requirements on business growth, innovation, and operational efficiency.
- How AI is revolutionizing regulatory compliance workflows and alleviating resource strain.
- The most pressing compliance challenges for 2025, from managing real-world data to addressing AI-related risks.
- Practical examples of AI-driven solutions helping businesses achieve compliance and avoid costly pitfalls.
Stay Ahead of Regulatory Complexities!
Download the 2025 State of Regulatory Affairs & Compliance Report now to empower your organization with the latest insights into navigating regulatory demands.
Equip your team with the tools to meet evolving compliance standards, protect business priorities, and leverage AI for a strategic advantage.
Ressources
World Antimicrobial Awareness Week (WAAW) 2024: Its Con…
World Antimicrobial Awareness Week (WAAW), celebrated annually from November 18-24, is a global campaign led by the World Health Organizatio…
En savoir plus
EU Commission to Adopt Regulation Banning BPA in All Fo…
The European Commission has announced the imminent adoption of a regulation banning bisphenol A (BPA) and other harmful bisphenols in Food C…
En savoir plus
EFSA Issues Scientific Opinion on Creatine and Cognitiv…
On November 19, 2024, the European Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods, and Food Allergens (NDA) issued a scientifi…
En savoir plus
NMPA Approves First Clinical Trial Application Under Pi…
On November 15, 2024, China’s National Medical Products Administration (NMPA) announced a milestone in its pilot program designed to optim…
En savoir plus
ANSM Publishes Comprehensive Overview on Antibiotic Con…
In alignment with World Antimicrobial Resistance Awareness Week, the French National Security Agency of Medicines and Health Products (ANSM)…
En savoir plus
Japan CAA Seeks Public Comments on Draft Revisions to G…
The Consumer Affairs Agency (CAA) of Japan has issued a call for public comments on proposed revisions to the Good Manufacturing Practices (…
En savoir plus